Cardiothoracic, orthopedic, vascular, and neurological diseases or disorders usually necessitate surgical treatment.
The global anesthesia CO2 absorbent market size is expected to reach USD 135.57 Million in 2030 and register a revenue CAGR of 9.1% over the forecast period, according to latest report by Reports and Data. The number of surgical procedures performed for the treatment of people suffering from neurological conditions, cardiac arrest, respiratory ailments, and diabetes has risen significantly. The number of accidents is also increasing with increasing global population, resulting in more surgical procedures being performed to save lives. This, in turn, is increasing demand for anesthesia, which is expected to drive market revenue growth over the forecast period. According to data published by National Center for Biotechnology Information (NCBI) in 2020, around 310 million major surgeries are performed globally each year; around 40 to 50 million in the U.S, and 20 million in Europe.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1365
Cardiothoracic, orthopedic, vascular, and neurological diseases or disorders usually necessitate surgical treatment. Higher frequency of surgical treatments, such as open-heart surgery for vein blockage treatment, as well as increasing prevalence of cardiovascular disease, arthritis, and cancer, are driving demand for general operations and thus, demand for anesthesia CO2 absorbent.
Manufacturers are embracing novel medical technologies to meet unmet patient demands, and several treatment methods have now become more streamlined, efficient, cost-effective, and less stressful for patients due to multiple product introductions. In December 2020, for instance, Smiths Medical announced that they had launched Portex EchoGlo peripheral nerve block portfolio. Development and launch of such new and advanced products is expected to play a major role in revenue growth of the global anesthesia CO2 absorbent market.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (U.S.), Allied Healthcare Products, Inc. (U.S.), Smiths Medical, Inc. (U.S.), Vyaire Medical, Inc. (U.S.), Intersurgical, Ltd. (England), Armstrong Medical, Ltd. (U.K.), Molecular Products Group, Ltd. (England), Micropore, Inc. (U.S.), Lowenstein Medical UK, Ltd. (England), and Atrasorb (Brazil).
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/anesthesia-co2-absorbent-market
Some Key Highlights From the Report
- In December 2020, Smiths Medical, a leading medical device manufacturer, announced the launch of its EchoGlo peripheral nerve block portfolio. This addition to the Portex portfolio of pain management products offers customers a complete solution for regional anesthesia from the pump to patient.
- Based on product, the market is segmented into soda lime, medisorb, dragersorb, amsorb, litholyme, and other products. The soda lime segment is expected to register a steady revenue CAGR of 2.1% over the forecast period, mainly due to supportive initiatives taken by governments of various countries and research & development initiatives to develop better CO2 absorbent formulations.
- Based on type, the market is segmented into traditional and premium. The premium segment is expected to register a robust revenue growth rate over the forecast period. The segment is expected to reach a value of USD 122.96 Million by 2030, registering a CAGR of 10.1% over the forecast period.
- Based on form, the market is segmented into granular form and powdered form. The powdered form segment is expected to register a faster revenue growth rate over the forecast period. There is increasing demand for powdered anesthesia CO2 absorbent than the granular form, which is made up of dusty, loose pellets, or granules that might shift and settle.
- Based on end user, the market is segmented into hospitals, clinics, and other end users. The hospitals segment accounted for largest revenue share in 2021 and is expected to register a significantly faster growth rate during the forecast period, due to factors such as presence of well-resourced operating rooms, increasing purchasing power of people, presence of highly skilled healthcare professionals in hospitals, and improved health coverage provided for hospital-based healthcare services by several private and group insurance plans.
- The Asia-Pacific anesthesia CO2 absorbent market is expected to register the fastest growth rate over the forecast period, due to increase in geriatric population, which is likely to result in significant increase in demand for surgeries in Asia-Pacific. The overall increase in the number of surgeries performed is expected to have a strong impact on the anesthesia CO2 absorbent market in Asia-Pacific, as anesthetic drugs are used in surgical procedures to reduce pain. The geriatric population is highly prone to degenerative diseases and chronic illnesses, which is expected to increase demand for surgeries and therapeutics, and thereby drive revenue growth of this market.
Anesthesia CO2 Absorbent Market Segmentation:
Product Outlook (Revenue, USD Million; 2019-2030)
- Soda Lime
- Medisorb
- Dragersorb
- Amsorb
- Litholyme
- Other Products
Type Outlook (Revenue, USD Million; 2019-2030)
- Traditional
- Premium
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1365
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data’s:
Antibody Production Market By Class (Monoclonal antibodies, Murine, Chimeric, Humanized, Polyclonal Antibodies), End User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Research Institutes), By Process And Segment Forecasts, 2020-2028
Anxiety Disorder and Depression Treatment Market By Therapies (Cognitive Behavior Therapy (CBT)), By Drug Class (Antidepressant Drugs, Selective Serotonin Reuptake Inhibitors (SSRIs)), By Devices, By Application, and End-users, And Segment Forecasts To 2028
Bioactive Wound Care Market Size, Share, Trends by Product Type (Moist Wound Care, Active Wound Care, and Antimicrobial Wound Care), By Wound Type, By End-user, And Segment Forecasts to 2028
Assisted Walking Device Market By Product Type (Wheelchairs, Walkers, Crutches), By Technologies (Low Tech, Mid Tech, High Tech), By Application, And Segment Forecasts, 2018-2028
Biodefense Market Size, Share, Trends, By Product Type (Anthrax Vaccine, Smallpox Vaccine, Botulism Vaccine, Radiation Vaccine, Others), By Application (Military and Civilian), By End-Use (Hospitals, Clinics, Others), and By Region Forecast to 2030
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs